Zelira Therapeutics (ASX:ZLD) Share Price and News

Market Cap (19-Sep) $5,948,577 (1,313th)	Close (30-Jun) $1.51 0 (0%)	Volume (30-Jun) 12,937	Shortsold (8-Aug) 2,108 (0.02%) (508th)
52w High $1.15	52w Low $0.310	P/E 5.78	EPS -0.32

	Subject
	ZLD ZLD Ann: Amendment to ASX announcement - Zelira's diabetic nerve pai
	1 (current) 2 3
	ZLD ZLD Ann: Initial Director's Interest Notice
	ZLD ZLD Ann: Final Director's Interest Notice
	ZLD ZLD Ann: Proposed issue of securities - ZLD
	ZLD ZLD Ann: Zelira Non-Executive Director Appointed
	ZLD ZLD Ann: Top Line Results Investor Presentation
	ZLD ZLD Ann: Investor Webinar - Top line trial results
	ZLD ZLD Ann: Zeliras diabetic nerve pain drug outperforms Lyrica
	ZLD ZLD Ann: Trading Halt
	ZLD ZLD Ann: ZLD secures additional US$3.25M investment in HOPE SPV
	ZLD ZLD Ann: Appendix 4C Cash Flow Report
	ZLD ZLD Ann: March 2023 Quarterly Activities Report
	ZLD ZLD Ann: Section 708A Cleansing Notice
	ZLD ZLD Ann: Application for quotation of securities - ZLD
	ZLD ZLD Ann: Proposed issue of securities - ZLD
	ZLD ZLD Ann: Zelira raises A$1.77 million from US-based investors
	ZLD ZLD Ann: Trading Halt
	ZLD ZLD Ann: Appendix 4D & FY23 Interim Financial Report
	ZLD ZLD Ann: Zelira HOPE 1 SPV Investor Presentation
	ZLD ZLD Ann: Initial Director's Interest Notice
	ZLD ZLD Ann: Zelira HOPE 1 SPV Investor Briefing Webinar
	ZLD ZLD Ann: Zelira Executive Director Appointed
	ZLD ZLD Ann: Trading Halt
	ZLD ZLD Ann: ZLD secures US$8.6 million funding for HOPE 1 US FDA trials
	ZLD ZLD Ann: Trading Halt
	ZLD ZLD Ann: Appendix 4C Cash Flow Report
	ZLD ZLD Ann: December 2022 Quarterly Activities Report
	ZLD ZLD Ann: Zelira receives $1.14 million cash R&D Tax Incentive
	ZLD ZLD Ann: Receipt of Creso Shares and Settlement of Health House loan
	ZLD ZLD Ann: Partial Receipt and variation of Health House loan
	ZLD ZLD Ann: HHI: Scheme implementation deed executed
	ZLD ZLD Ann: ZLD Completes Enrolment for Diabetic Nerve Pain Drug Trial
	ZLD ZLD Ann: New Constitution
	ZLD ZLD Ann: Results of Meeting
	ZLD ZLD Ann: 2022 Annual General Meeting Presentation
	ZLD ZLD Ann: Zelira Retail Investor Presentation
	ZLD ZLD Ann: Sydney Retail Investor Briefing Time Change
	ZLD ZLD Ann: Zelira Retail Investor Briefing Details
	ZLD ZLD Ann: Appendix 4C Cash Flow Report
	ZLD ZLD Ann: September 2022 Quarterly Activities Report
	ZLD ZLD Ann: Notice of Annual General Meeting/Proxy Form
	ZLD ZLD Ann: Letter to Shareholders
	ZLD ZLD Ann: Notification of cessation of securities - ZLD
	ZLD ZLD Ann: Diabetic Nerve Pain Drug Trial Summary Update
	ZLD ZLD Ann: AGM Date and Closing Date for Director Nominations
	ZLD ZLD Ann: Annual Report to shareholders
	ZLD ZLD Ann: ZLDs Diabetic Nerve Pain Drug Trial Two-Thirds Enrolled
	ZLD ZLD Ann: Partial Receipt of Health House Loan
	ZLD ZLD Ann: Investor Briefing Webinar Presentation
	ZLD ZLD Ann: Investor Briefing Webinar Details

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Incannex Healthcare

IHL

Medical Developments International

MVP

Mayne Pharma Group

MYX

Neuren Pharmaceuticals

NEU

Probiotec

PBP

Recce Pharmaceuticals Ltd

RCE

Starpharma Holdings

SPL

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.47	5,174	+0.06 (14.63%)
12-Sep	$0.41	3,122	+0.04 (9.33%)
11-Sep	$0.38	2,479	+0.02 (4.17%)
05-Sep	$0.36	5,773	+0.01 (2.86%)
04-Sep	$0.35	1,776	-0.06 (14.63%)
03-Sep	$0.41	589	-0.04 (8.89%)
29-Aug	$0.45	983	+0.02 (4.65%)
28-Aug	$0.43	161	+0.02 (3.61%)
22-Aug	$0.42	692	0.00 (0.00%)
21-Aug	$0.42	850	+0.01 (1.22%)
15-Aug	$0.41	80	-0.01 (2.38%)
14-Aug	$0.42	2,144	+0.01 (2.44%)
07-Aug	$0.41	1,416	0.00 (0.00%)
31-Jul	$0.41	3,086	0.00 (0.00%)
30-Jul	$0.41	635	0.00 (0.00%)
8 up, 3 down, and 4 flat days

High $1.54	Low $1.51	Trades 21	Turnover $19,629	Volume 12,937
30 June 2023 at 3:54pm

High $1.54	Low $1.51	Trades 21	Turnover $19,629	Volume 12,937
30 June 2023 at 3:54pm

Zelira Therapeutics Health Care

$1.51 (0%)

$1.51 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices